Prevalence of HCV infection in patients on haemodialysis: Survey by antibody and core antigen detection

Indian Journal of Medical Microbiology

Volumn 23, Issue 2, 2005, Pages 106-110

  Reddy, A K ^a   Murthy, K V D ^b   Lakshmi, V ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b Nizam's Institute of Medical Sciences   (United States)

Author keywords

Chronic renal failure; HCV c Ag; Seroconversion

Indexed keywords

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH SURVEY; HEMODIALYSIS; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SEROCONVERSION; VIRUS IDENTIFICATION;

EID: 19044371507     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.16049     Document Type: Article

References (27)

1. Meyers CM, Seeff LB, Breen CO, Hoofangle JH. Hepatitis C and renal disease: Update. Am J Kidney Dis 2003;42:631-57.
2. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patients with end stage renal disease. Hepatology 2002;36:3-10.
3. Froio N, Nicastri E, Comandini UV, Cherubini C, Felicioni F, Solmone M, et al. Contamination by hepatitis B and C viruses in dialysis setting. Am J Kidney Dis 2003;42:546-50.
4. Bdour S. Hepatitis C virus infection in Jordanian Hemodialysis units: Serological diagnosis and genotyping. J Med Microbiol 2002;51:700-4.
5. Fissell RB, Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of Hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 2004;65:2335-42.
6. Dalekos GN, Boumba DS, Katopodis K, Zervou E, Sferopoulos G, Elisaf M, et al. Absence of HCV viremia in anti-HCV negative hemodialysis patients. Nephrol Dial Transplant 1998;13:1804-6.
7. Devesa M, Khudyakov YE, Capriles F, Blitz L, Fields HA, Liprandi F, et al. Reduced antibody reactivity to Hepatitis C Virus antigens in Hemodialysis patients co infected with Hepatitis B Virus. Clin Diagn Lab Immunol 1997;4:639-42.
8. Agarwal SK, Dash SC, Irshad M. Hepatitis C Virus infection during hemodialysis in India. J Assoc Physic Ind 1999;47:1139-43.
9. Bourveir M, Patel K, Dahari H, Beaucourt S, Larderie R, Blatt L, et al. Clinical utility of HCV core antigen quantification: A new indirect marker of HCV replication. Hepatology 2002;36:211-8.
10. Lok AS, Chien D, Choo QL, Chan TM, Chiu EK, Cheng IK, et al. Antibody response to core, envelope and non-structural Hepatitis C Virus antigens: Comparison of immunocompetent and immunosupressed patients. Hepatology 1993;18:497-502.
11. Moreira R, Pinho JR, Fares J, Oba IT, Cardoso MR, Saraceni CP, et al. Prospective study of Hepatitis C Virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol 2003;49:503-7.
12. Schiff ER, Medina MD, Khan S. New perspectives in the diagnosis of Hepatitis C. Semin Liver Dis 1999;19:3-15.
13. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997;26:43s-7s.
14. Young KK, Archer JJ, Yokosuka O. Detection of hepatitis C RNA by a combined reverse transcription PCR assay Comparison with nested amplification and antibody testing. J Clin Microbiol 1995;33:654-7.
15. Saab S, Brezina M, Gitnick G, Martin P, Yee HF. Hepatitis C screening strategies in Hemodialysis patients. Am J Kidney Dis 2001;38:91-7.
16. Salunkhe PN, Naik SR, Semwal SN, Naik S, Kher V. Prevalence of antibodies to Hepatitis C Virus in HBs Ag negative hemodialysis patients. Indian J Gastroenterol 1992;11:164-5.
17. Chadha MS, Arankalle VA, Jha J, Banerjee K. Prevalence of Hepatitis B and C virus infection among hemodialysis in Pune (Western India). Vox Sang 1993;64:127-8.
18. Sumathi S, Valliammai T, Thyagarajan SP, Malathy S, Madanagopalan N, Sankarnarayan V, et al. Prevalence of hepatitis C virus infection in liver disease, renal disease and voluntary blood donors in south India. Indian J Med Microbiol 1993;11:291-7.
19. Jaiswal SP, Chitnis DS, Salgia P, Sepaha A, Pandit CS. Prevalence of hepatitis viruses among chronic renal failure patients on hemodialysis in central India. Dialys Transplant 2002;31:234-8.
20. Hinrichsen H, Leimnstoll G, Stegen G, Shrader H, Folsch UR, Schmidt WE, Prevalence and risk factors of Hepatitis C Virus infection in hemodialysis patient's multi center study in 2796 patients. Gut 2002;51:429-33.
21. Uyttendale S, Clayes H, Mertens W, Verhaert H, Vermylen. Evaluation of third generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994;66:122-9.
22. Schneerberger PM, Keur I, Vliet W, Hoek K, Boswijk H, Loon AM, et al. Hepatitis C virus infection in dialysis centers in The Netherlands: national survey by serological and molecular methods. J Clin Microbiol 1998;36:1711-5.
23. Lai KN. Hepatitis C infection screening in hemodialysis units. Am J Kidney Dis 2001;38:186-8.
24. Lee SR, Peterson J, Niven P, Bahl C, Page E. Efficacy of Hepatitis C core antigen enzyme linked Immuno Sorbent assay for the identification of window phase blood donations. Vox Sang 2001;80:19-23.
25. Peterson J, Green G, Lida K, Well CB, Aoyagi K. Detection of Hepatitis C core antigen in antibody negative window phase of Hepatitis C infection. Vox Sang 2000;78:80-5.
26. Courouce AM, Marrec NL, Bouchardeau F, Razer A, Maniez M, Laperche S, et al. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 2000;40:1198-202.
27. Devesa M, Saez A, Leon G, Sirit F, Cosson C, Bermudez H, et al. Restricted isotypic antibody reactivity to Hepatitis C Virus synthetic peptides in immunocompromised patients. Clin Diagn Lab Immunol 1999;6:279-81.